We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.63B
AUM Growth
-$333M
Cap. Flow
-$7.68M
Cap. Flow %
-0.47%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$7.68M

Sector Composition

Rank Sector Weight
1 Healthcare 55.79%
2 Consumer Staples 27.46%
3 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$784M 48.16%
8,592,007
-71,577
-0.8% -$7.68M
MNST icon
2
Monster Beverage
MNST
$94.3B
$447M 27.46%
9,312,976
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$153M 9.42%
690,000
AXON
4
Axon Enterprise
AXON
$42.5B
$119M 7.33%
760,062
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$83.3M 5.12%
34,005,379
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$37.6M 2.31%
867,497
SER icon
7
Serina Therapeutics
SER
$30M
$3.27M 0.2%
85,219

Similar funds

Broadwood Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Broadwood Capital held 7 positions worth $1.63B, down 17% from $1.96B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 64% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital's biggest Q4 2021 reduction was STAAR Surgical, cutting an estimated $7.68M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.63B portfolio in Q4 2021.
  • Broadwood Capital opened 0 new positions and closed 0 in Q4 2021.
  • Broadwood Capital's portfolio value fell 17% quarter-over-quarter to $1.63B.

Based on Broadwood Capital's 13F filing for Q4 2021, filed 14 Feb 2022.